Maynard Um
-
-
-
-
-
-
-
Allogene publishes preclinical data for dual-targeted autoimmune CAR T
-
-
-
-
-
-
-
Allogene (ALLO) PT Raised to $9 at Baird
-
-
-
-
-
-
-
Allogene outlines 2026 clinical milestones for CAR-T therapies
-
-
-
-
-
-
-
Allogene Therapeutics, Inc. (ALLO) Tops Q2 EPS by 4c
-
-
-
-
-
-
-
Bernstein flags 14 biotechs exploring strategic options, possible M&A
-
-
-
-
-
-
-
Allogene Therapeutics, Inc. (ALLO) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Allogene (ALLO)
-
427,663 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

